CSIMarket


Organicell Regenerative Medicine Inc   (BPSR)
Other Ticker:  
 
 

BPSR's Net Cash Flow Growth by Quarter and Year

Organicell Regenerative Medicine Inc 's Net Cash Flow results by quarter and year




BPSR Net Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter October - 0.27 0.10 -0.01
III Quarter July -0.17 0.06 -0.08 -0.03
II Quarter April 0.13 0.11 0.11 -0.05
I Quarter January -0.52 0.01 -0.03 -
FY   -0.56 0.45 0.10 -0.09



BPSR Net Cash Flow third quarter 2021 Y/Y Growth Comment
Organicell Regenerative Medicine Inc in the third quarter recorded net cash outflow of $ -0.17 millions.

According to the results reported in the third quarter, Organicell Regenerative Medicine Inc achieved the best Net Cash Flow growth in Biotechnology & Pharmaceuticals industry. While Organicell Regenerative Medicine Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the third quarter.




BPSR Net Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter October - 170 % - -
III Quarter July - - - -
II Quarter April 18.18 % 0 % - -
I Quarter January - - - -
FY   - 350 % - -

Financial Statements
Organicell Regenerative Medicine Inc 's third quarter 2021 Net Cash Flow $ -0.17 millions BPSR's Income Statement
Organicell Regenerative Medicine Inc 's third quarter 2020 Net Cash Flow $ 0.06 millions Quarterly BPSR's Income Statement
New: More BPSR's historic Net Cash Flow Growth >>


BPSR Net Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter October - 350 % - -
III Quarter July - -45.45 % - -
II Quarter April - 1000 % - -
I Quarter January - -90 % - -
FY (Year on Year)   - 350 % - -




Net Cash Flow third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Organicell Regenerative Medicine Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BPSR's III. Quarter Q/Q Net Cash Flow Comment
Recent results of -0.17 millions by Organicell Regenerative Medicine Inc come out even worse compare to the 0.13 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Organicell Regenerative Medicine Inc achieved highest sequential Net Cash Flow growth. While Organicell Regenerative Medicine Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BPSR's III. Quarter Q/Q Net Cash Flow Comment
III. Quarter 2021 results of -0.17 millions by Organicell Regenerative Medicine Inc come out even worse considering the 0.13 millions net cash outflow a quarter before.

Within Biotechnology & Pharmaceuticals industry Organicell Regenerative Medicine Inc achieved highest sequential Net Cash Flow growth. While Organicell Regenerative Medicine Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Organicell Regenerative Medicine Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Jul 31 2021)
12 Months Ending
(Apr 30 2021)
12 Months Ending
(Jan 31 2021)
12 Months Ending
(Oct 31 2020)
12 Months Ending
(Jul 31 2020)
Cumulative Net Cash Flow 12 Months Ending $ -0.29 $ -0.06 $ -0.08 $ 0.46 $ 0.28
Y / Y Net Cash Flow Growth (TTM) - - - 411.77 % 1604.15 %
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - 63.44 % 111.11 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
Organicell Regenerative Medicine Inc realized trailing twelve months net cash outflow of $ -0 millions, in the Jul 31 2021, compare to Net Cash Flow of $ 0 millions a year ago.

Organicell Regenerative Medicine Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
Organicell Regenerative Medicine Inc realized trailing twelve months net cash outflow of $ -0 millions, in the Jul 31 2021, compare to Net Cash Flow of $ 0 millions a year ago.

Organicell Regenerative Medicine Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BPSR's Net Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BPSR's Competitors
Net Cash Flow Growth for Organicell Regenerative Medicine Inc 's Suppliers
Net Cash Flow Growth for BPSR's Customers

You may also want to know
BPSR's Annual Growth Rates BPSR's Profitability Ratios BPSR's Asset Turnover Ratio BPSR's Dividend Growth
BPSR's Roe BPSR's Valuation Ratios BPSR's Financial Strength Ratios BPSR's Dividend Payout Ratio
BPSR's Roa BPSR's Inventory Turnover Ratio BPSR's Growth Rates BPSR's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Jul 31 2021 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Jul 31 2021
Exelixis Inc -29.69%$ -29.695 millions
Envista Holdings Corporation-75.96%$ -75.960 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IPVA's Profile

Stock Price

IPVA's Financials

Business Description

Fundamentals

Charts & Quotes

IPVA's News

Suppliers

IPVA's Competitors

Customers & Markets

Economic Indicators

IPVA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071